Contact US
PredictDb

Product Sheets

PredictDb

Access the largest collection of Patient-Derived Cell (PDC) model data anytime and from anywhere

Read More

AACR 2022

Posters

AACR 2022

Discover our research presented at the 2022 AACR annual meeting

Read More

predictRx

Product Sheets

predictRx

predictRx is Imagen’s pioneering in vitro diagnostic platform that helps oncologists find the right treatment for each unique cancer patient...

Read More

predictTx

Product Sheets

predictTx

predictTx is Imagen’s suite of in vitro pharmacology services that harness the power of 100’s of clinically relevant 2D and...

Read More

Imagen Services Portfolio

Product Sheets

Imagen Services Portfolio

Discover the power of our Patient-derived cell (PDC) model and high content imaging platform. Lengthy and costly drug development programs...

Read More

AACR Annual Meeting 2022

Meet Us

AACR Annual Meeting 2022

Imagen will be showcasing its research at the AACR Annual Meeting on April 8th — 13th in New Orleans. Join...

Read More

Can PDC models improve oncology drug attrition rates?

Blogs

Can PDC models improve oncology drug attrition rates?

A large and well characterised biobank of patient-derived cell models can significantly accelerate drug development timelines and fast track decisions...

Read More

When and how to use PDC in drug development

Blogs

When and how to use PDC in drug development

So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...

Read More

Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle

Posters

Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle

Patient-derived cell (PDC) models bridge the gap between conventional cancer lines that do not faithfully replicate clinical responses and costly...

Read More

Differential sensitivity to poly (ADP-ribose) polymerase inhibitors in patient-derived cell models of breast cancer

Posters

Differential sensitivity to poly (ADP-ribose) polymerase inhibitors in patient-derived cell models of breast cancer

New treatment strategies are urgently needed for metastatic breast cancer, which remains an area of high unmet need with poor...

Read More

Next generation in vitro models for oncology R&D – relevance is key

Blogs

Next generation in vitro models for oncology R&D – relevance is key

So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...

Read More

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Contact Us

© Copyright 2022 Imagen Therapeutics Ltd